Discover the latest news on treatments and emerging drugs

A webinar exploring the fast-changing landscape of treatments for age-related macular degeneration (AMD) will be hosted by OcuPlan this month.

The company, which offers a payment plan for people with macular disease and other eye conditions, will host the free event to update on the most recently approved treatments, as well as emerging drugs.

The webinar 

Leading the webinar will be one of the company’s very own ophthalmologists, James Neffendorf, renowned for his expertise in medical retinal, macula, and cataract services.

Founded by consultant ophthalmologist Dan Calladine, OcuPlan is designed to give patients with long-term eye conditions, such as macular disease, affordable access to specialist care and prevent unnecessary sight loss.

OcuPlan has a network of consultant ophthalmologists and opticians across the UK available to support patients with AMD and can provide quick access to a local ophthalmologist.

Macular Society and Ocuplan partnership 

The Macular Society is excited to announce that we are continuing to work with OcuPlan in 2024, with the company contributing an additional £50,000 to support groundbreaking research and vital support services.

Dan Calladine, Founder of OcuPlan, said: “I’m thrilled that OcuPlan and the Macular Society are continuing our partnership into a second year. The first year has been a huge success for us not only in further developing our offering to truly help people living with AMD, but also in achieving our objectives of reaching new audiences to educate them on the importance of early diagnosis.”

OcuPlan’s webinar is taking place on Wednesday 24 April at 7pm.